Your browser doesn't support javascript.
loading
Development and Characterization of a Tacrolimus/Hydroxypropyl-ß-Cyclodextrin Eye Drop.
García-Otero, Xurxo; Díaz-Tomé, Victoria; Varela-Fernández, Rubén; Martín-Pastor, Manuel; González-Barcia, Miguel; Blanco-Méndez, José; Mondelo-García, Cristina; Bermudez, Maria A; Gonzalez, Francisco; Aguiar, Pablo; Fernández-Ferreiro, Anxo; Otero-Espinar, Francisco J.
Afiliación
  • García-Otero X; Pharmacology, Pharmacy and Pharmaceutical Technology Department, Faculty of Pharmacy, University of Santiago de Compostela (USC), 15705 Santiago de Compostela, Spain.
  • Díaz-Tomé V; Molecular Imaging Group, University Clinical Hospital, Health Research Institute of Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain.
  • Varela-Fernández R; Pharmacology, Pharmacy and Pharmaceutical Technology Department, Faculty of Pharmacy, University of Santiago de Compostela (USC), 15705 Santiago de Compostela, Spain.
  • Martín-Pastor M; Clinical Pharmacology Group, University Clinical Hospital, Health Research Institute of Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain.
  • González-Barcia M; Pharmacology, Pharmacy and Pharmaceutical Technology Department, Faculty of Pharmacy, University of Santiago de Compostela (USC), 15705 Santiago de Compostela, Spain.
  • Blanco-Méndez J; Clinical Neurosciences Group, University Clinical Hospital, Health Research Institute of Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain.
  • Mondelo-García C; Nuclear Magnetic Resonance Unit, Research Infrastructures Area, University of Santiago de Compostela, Campus Vida, 15782 Santiago de Compostela, Spain.
  • Bermudez MA; Clinical Pharmacology Group, University Clinical Hospital, Health Research Institute of Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain.
  • Gonzalez F; Pharmacology, Pharmacy and Pharmaceutical Technology Department, Faculty of Pharmacy, University of Santiago de Compostela (USC), 15705 Santiago de Compostela, Spain.
  • Aguiar P; Paraquasil Group, University Clinical Hospital, Health Research Institute of Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain.
  • Fernández-Ferreiro A; Clinical Pharmacology Group, University Clinical Hospital, Health Research Institute of Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain.
  • Otero-Espinar FJ; Physiology Department-CIMUS, University of Santiago de Compostela (USC), 15782 Santiago de Compostela, Spain.
Pharmaceutics ; 13(2)2021 Jan 23.
Article en En | MEDLINE | ID: mdl-33498753
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Pharmaceutics Año: 2021 Tipo del documento: Article País de afiliación: España
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Pharmaceutics Año: 2021 Tipo del documento: Article País de afiliación: España